| [1] | Posner GH and Kahraman M. (2003) Organic chemistry of vita- min D analogues (deltanoids). European Journal of Organic Chemistry, 20, 3889- 3895. | 
                     
                                
                                    
                                        | [2] | Babina M, Krautheim M, Grutzkau A, et al. (2000) Human leukemic mast cells (HMC-1) are responsive to 1-alpha, 25- dihydroxyvitamin D3: Selective promotion of ICAM- 3 ex- pression and constitutive presence of vitaminD3 receptor. Bio- chemical and Biophysical Research Communications, 273, 1104- 1110. | 
                     
                                
                                    
                                        | [3] | Li XY, Boudjelal M, Xiao JH, et al. (1999) 1, 25-di- hydroxyvitamin D3 increase nuclear vitamin D receptors by blocking ubiquitin/proteasome-mediated degradation in human skin. Molecular Endocrinology, 13, 1686-1694. | 
                     
                                
                                    
                                        | [4] | Chen TC, Schwartz GG, Burnstein KL, et al. (2000) The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1,25-dihydroxy- vitamin D2 as therapeutic agents for prostate cancer. Clinical Cancer Research, 6, 901-908. | 
                     
                                
                                    
                                        | [5] | Brown AJ. (2001) Therapeutic uses of vitamin D analogues. American Journal of Kidney Diseases, 38, 3-19. | 
                     
                                
                                    
                                        | [6] | Goltzman D, Miao DS, Panda DK, et al. (2004) Effect of cal- cium and the vitamin D system on skeletal and calcium homeo- stasis: lessons from genetic models. The Journal of Steroid Bio- chemistry and Molecular Biology, 89-90, 485-489. | 
                     
                                
                                    
                                        | [7] | Yamada S, Shimizu M and Yamamoto K. (2003) Structure- function relationships of vitamin D including ligand recognition by the vitamin D receptor. Medicinal Research Reviews, 23, 89- 115. | 
                     
                                
                                    
                                        | [8] | Enrico G. Baggiolini, Jerome A. Iacobelli and Bernard M. (1986) Hennessy, stereocontrolled total synthesis of 1, 25-dihydroxy- cholecalciferol and 1, 25-Dihydroxycholecalciferol. The Journal of Organic Chemistry, 51, 3098-3105. | 
                     
                                
                                    
                                        | [9] | William S. Johnson, John D. Elliott and Gunnar J. (1984) Hanson asymmetrie synthesis via acetal templates.6.a stereo- selective approach to a key intermediate for the preparation of vitamin D metabolites. Journal of the American Chemical So- ciety, 106, 1138-1139. | 
                     
                                
                                    
                                        | [10] | Paaren HE, Deluca HF and Schnoes HK. (1980) Direct C(1) hy- droxylation of vitamin D3 and related compounds. The Journal of Organic Chemistry, 45, 3253-3258. | 
                     
                                
                                    
                                        | [11] | Tadashi Sato, Hiroshi yamauchi and Yoshitake Ogata. (1978) Studies on 1-hydroxyl derivatives of vitamin D3. I. syntheses of 1-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3. Chemical and Pharmaceutical Bulletin, 25, 2983-2940. | 
                     
                                
                                    
                                        | [12] | DeLuca. (1985) Method for preparing 1-hydroxyvitamin D compounds. US 4554106. |